219 summarised stories about AI & Healthcare, each linking back to the original source. Browse all topics →
Tech.eu 3 days ago 5 ● 2 sources
Scarlet raised a $50 million Series B as a certification body for AI and software medical devices. The funding round was led by Headline. The company plans to expand in the United States and Asia-Pacific, add AI reviewers and engineers, and broaden its certification offerings, to shorten certification timelines for AI device updates.
Tech Funding News 3 days ago 24 ● 2 sources
Scarlet, founded by former Babylon Health engineers, raised a Series B financing round to speed certification of AI medical devices via regulatory review. The company secured $50 million led by Headline, alongside Notion Capital joining other existing investors. The funding will be used to expand in the US and Asia-Pacific and hire more AI reviewers and engineers to support faster device approvals.
Tech Funding News 3 days ago 20
Matter Machine completed a £4M pre-Series A funding round and recruited Oxford Nanopore co-founder Gordon Sanghera to lead commercialisation strategy for AI-driven materials discovery. The round was led by IP Group and was £4M. This support will expand the team, develop its AI-plus-experiment platform, and pursue commercial partner contacts against better-funded competitors like CuspAI.
The daily briefing
TLDRocket reads all relevant sources, removes duplicate coverage, and summarises the day in two minutes. Follow companies and topics for alerts, or get the briefing in Slack. Free, no spam, unsubscribe anytime.
TLDRocket
15 October 2026
Anthropic’s IPO momentum dominated today’s AI news, and the details read like a pitch built for CFOs, not just researchers. The company told investors its third-quarter revenue hit $16.8 billion, up about 46% quarter over quarter and nearly 50% in the story’s framing, putting it on a clear path toward public-market scrutiny. Crucially for the valuation talk, distillation—how labs compress and reuse model knowledge—contributed only 5% to 7% of revenue before being “cut back materially” in Q3, shifting the mix away from spending and dependencies that other labs leaned on. An early backer’s market-odds math expects shares priced around $1.8 trillion with a trading value of $2.3 to $2.4 trillion, even comparing that jump to SpaceX’s roughly $2.1 trillion opening-day market cap.
Read the full briefing →